42. Noack B, Genco RJ, Trevisan M, et al. Periodontal infections 49. Malik S, Wong ND, Franklin S, et al. Cardiovascular disease in contribute to elevated systemic C-reactive protein level. J U.S. patients with metabolic syndrome, diabetes, and elevated C- Periodontol 2001;72:1221-1227. reactive protein. Diabetes Care 2005;28:690-693.

43. Amar S, Gokce N, Morgan S, et al. Periodontal disease is associated 50. Festa A, Jr. D’Agostino R, Howard G, et al.Chronic subclinical with brachial artery endothelial dysfunction and systemic inflammation as part of the insulin resistance syndrome: the inflammation. Arterioscler Thromb Vasc Biol 2003;23:1245- Insulin Resistance Atherosclerosis Study (IRAS). Circulation 1249. 2000;102: 42-47.

44. Slade GD, Ghezzi EM, Heiss G, et al. Relationship between 51. Festa A, Jr. D’Agostino R, Tracy RP, Haffner SM. Elevated levels periodontal disease and C-reactive protein among adults in the of acute-phase proteins and plasminogen activator inhibitor- 1 Atherosclerosis Risk in Communities study. Arch Intern Med predict the development of type 2 diabetes: the insulin resistance 2003;163:1172-1179. atherosclerosis study. Diabetes 2002;51:1131-1137.

45. Leivadaros E, van der Velden U, Bizzarro S, et al. A pilot study into 52. Saremi A, Nelson RG, Tulloch-Reid M, et al. Periodontal disease measurements of markers of atherosclerosis in periodontitis. J and mortality in type 2 diabetes. Diabetes Care 2005;28: 27-32 Periodontol 76:121-128. 53. Brown DL, Golub LM, Lee H, et al. Effect of subantimicrobial

46. Shanies S, Hein C. The significance of periodontal infection in doxycycline on biomarkers in patients with acute coronary cardiology. Grand Rounds 2006;1: 24-33. syndromes. J Dent Res Spec issue. 2003.

47. Rifai N and PM Ridker. Proposed cardiovascular risk assessment 54. [no authors listed]. Effect of intensive diabetes management on algorithm using high-sensitivity C-reactive protein and lipid macrovascular events and risk factors in the Diabetes Control screening. Clin Chem 2001;47: 28-30. and Complications Trial. Am J Cardiol 1995;75:894-903.

48. Sprafka JM, Burke GL, Folsom AR, et al. Trends in prevalence 55. [no authors listed]. The relationship of glycemic exposure (HbA1c) of diabetes mellitus in patients with myocardial infarction and to the risk of development and progression of retinopathy in the effect of diabetes on survival. The Minnesota Heart Survey. diabetes control and complications trial.1995; Diabetes 44:968- Diabetes Care 1991;14:537-543. 983.